Validation of Fluorescence In Situ Hybridization Using an Analyte-Specific Reagent for Detection of Abnormalities Involving the Mixed Lineage Leukemia Gene | Citedby Results | Archives of Pathology & Laboratory Medicine

Skip to Main Content

Skip Nav Destination

Validation of Fluorescence In Situ Hybridization Using an Analyte-Specific Reagent for Detection of Abnormalities Involving the Mixed Lineage Leukemia Gene

Arch Pathol Lab Med (2012) 136 (1): 47–52.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Real world outcome of high-risk multiple myeloma: an Indian tertiary care centre experience

Anveshika Soni
Sujay Rainchwar
Reema Singh
Dikshat Gopal Gupta
Nakul Tikare
Rohan Halder
Roy J Palatty
Vipul Sharad Sheth
Narendra Agrawal
Dinesh Bhurani
Tribikram Panda

Clinical Lymphoma Myeloma and Leukemia (2024)

Utility of Fluorescence In Situ Hybridization in Clinical and Research Applications

Gail H. Vance
Wahab A. Khan

Clinics in Laboratory Medicine (2022) 42 (4): 573.

Role of cytogenetic abnormalities detected by fluorescence in situ hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemia

Dhanlaxmi Shetty
Hemani Jain
Yogita Rohil
Navin Khattry
Manju Sengar
Bhausaheb Bagal
Hasmukh Jain
Anant Gokarn
Sachin Punatar
VenkataNaga Avinash Bonda
PG Subramanian

Indian Journal of Medical Research (2021) 153 (4): 475.

Utility of Fluorescence In Situ Hybridization in Clinical and Research Applications

Gail H. Vance
Wahab A. Khan

Advances in Molecular Pathology (2020) 3: 65.

One-fits-all pretreatment protocol facilitating Fluorescence In Situ Hybridization on formalin-fixed paraffin-embedded, fresh frozen and cytological slides

Shivanand O. Richardson
Manon M. H. Huibers
Roel A. de Weger
Wendy W. J. de Leng
John W. J. Hinrichs
Ruud W. J. Meijers
Stefan M. Willems
Ton L. M. G. Peeters

Molecular Cytogenetics (2019) 12 (1)

Reply to Chou et al ‘Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution’ Mod Pathol 2017; in press.

Sean R Williamson
David J Grignon
Anna Calió
Bradley A Stohr
John N Eble
Liang Cheng

Modern Pathology (2017) 30 (10): 1509.

Utilization of Chromogenic In Situ Hybridization to Assess Ploidy in the Diagnosis of Hydatidiform Mole

John P. Kunesh
Jacqueline G. Kunesh
Rachel Jade Jorgensen
Catrina D. Corral
John D. Blakey

American Journal of Clinical Pathology (2016) 146 (1): 125.

Methods-Based Proficiency Testing in Molecular Genetic Pathology

Iris Schrijver
Nazneen Aziz
Lawrence J. Jennings
Carolyn Sue Richards
Karl V. Voelkerding
Karen E. Weck

The Journal of Molecular Diagnostics (2014) 16 (3): 283.

Cancer Cytogenetics: Methodology Revisited

Thomas S. K. Wan

Annals of Laboratory Medicine (2014) 34 (6): 413.

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal I. Lindeman
Philip T. Cagle
Mary Beth Beasley
Dhananjay Arun Chitale
Sanja Dacic
Giuseppe Giaccone
Robert Brian Jenkins
David J. Kwiatkowski
Juan-Sebastian Saldivar
Jeremy Squire
Erik Thunnissen
Marc Ladanyi

Archives of Pathology & Laboratory Medicine (2013) 137 (6): 828.

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal I. Lindeman
Philip T. Cagle
Mary Beth Beasley
Dhananjay Arun Chitale
Sanja Dacic
Giuseppe Giaccone
Robert Brian Jenkins
David J. Kwiatkowski
Juan-Sebastian Saldivar
Jeremy Squire
Erik Thunnissen
Marc Ladanyi

Journal of Thoracic Oncology (2013) 8 (7): 823.

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

Neal I. Lindeman
Philip T. Cagle
Mary Beth Beasley
Dhananjay Arun Chitale
Sanja Dacic
Giuseppe Giaccone
Robert Brian Jenkins
David J. Kwiatkowski
Juan-Sebastian Saldivar
Jeremy Squire
Erik Thunnissen
Marc Ladanyi

The Journal of Molecular Diagnostics (2013) 15 (4): 415.

The Role of Fish in Hematologic Cancer

Thomas S K Wan
Edmond S K Ma

International Journal of Hematologic Oncology (2012) 1 (1): 71.